Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Administration of Allogenic Mononuclear Cord Blood Cells in Patients With Acute Severe Contusion Spinal Cord Injury: Safety and Efficiency Evaluation, Stages I/II

NCT05693181 is registered in ClinicalTrials.gov with Sklifosovsky Institute of Emergency Care as lead sponsor.

NCT NCT05693181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05693181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Administration of Allogenic Mononuclear Cord Blood Cells in Patients With Acute Severe Contusion Spinal Cord Injury: Safety and Efficiency Evaluation, Stages I/II
Lead sponsor
Sklifosovsky Institute of Emergency Care
Phase
Phase 1/2
Overall status
Unknown status
Start date
December 5, 2022
Completion date
August 30, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury, acute